Healthcare in Asia 2012

Healthcare in Asia 2012
March 28th 2012 - March 29th 2012
  • The Fullerton Hotel Singapore

More than 200 participants across Asia and around the world—including health ministers, policymakers, practitioners, senior pharmaceutical executives and academics—gathered in Singapore on March 28th and 29th at the third Healthcare in Asia roundtable.

Building on the last two successful events, Healthcare in Asia 2012 once again created a forum for stimulating discussions on the most cutting-edge topics in relation to health policy and reforms.  The key theme was why and how to use health outcomes to assess the efficiency and effectiveness of health systems in Asia.

Evidence-based clinical outcomes are replacing inputs and process as targets against which healthcare systems are assessed in some developed markets. This innovative approach is in the vanguard of reforms and is already evident in a small number of Asian countries, notably in Singapore.

Gan Kim Yong, Minister of Health of Singapore, in the keynote address, shared how Singapore is in the midst of restructuring its health system to deliver good outcomes in the city-state.

On a panel, health ministers from Malaysia, Indonesia and the Philippines shared how they are reshaping their respective healthcare systems, with rapidly aging societies and the growing burden of non-communicable diseases.

Other highlights included an interview with Paula Risikko, Minister of Social Affairs and Health, Finland and executive interviews with Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence (NICE) from the UK and Wyatt Decker, Vice President of Mayo Clinic, a leading non-profit, patient-centred healthcare system in the US.

Other government leaders, academics, policy makers and expert industry stakeholders who participated in Healthcare in Asia 2012 include Shi Guang, Director, Health Policy Research Division, Ministry of Health, China; Paula Wilson, President and Chief executive officer, Joint Commission Resources and Joint Commission International; Anil Kapur, Managing Director, World Diabetes Foundation; Mary Gospodarowicz, President-Elect, Union for International Cancer Control and others.

Discussions at the conference were led by Charles Goddard, editorial director, Asia-Pacific, Economist Intelligence Unit and Simon Long, Asia Columnist, The Economist.

Throughout the one and half day event, attendees and people outside the conference were invited to share and follow live updates via our social media campaign on twitter and LinkedIn.

     

View photo highlights of the day: 

Get the flash player here: http://www.adobe.com/flashplayer

Healthcare in Asia 2012

Healthcare outcomes in Asia: a new approach for efficiency and effectiveness 

DAY 1

8.00am 

Registration and refreshments

 

8.45am 

Conference vision

Introduction from the chairman on the background, vision and objectives of the Healthcare in Asia 2012 roundtable

Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit

 

9.05am 

Scene setting interview

Revisiting the goals—Why structure healthcare systems around clinical outcomes?

England's National Health Service is undergoing a major shift in thinking towards a primarily outcomes-oriented framework for improving healthcare quality and performance and raising health outcomes. Variants of this approach-in which evidence-based clinical outcomes are replacing inputs and process as targets against which healthcare systems are assessed-are in the vanguard of reforms in mature healthcare systems, here in Asia and around the world. The issues are complex, and the challenges considerable but the new path being beaten arguably has relevance for all.

  • How is the NHS' outcomes-oriented framework qualitatively different from previous performance measures?
  • Are outcomes measures alone sufficient for improving performance?
  • How can outcomes targets be applied at the clinical, planning and system levels? What are the challenges of shifting to such an approach?
  • How can public health and healthcare outcomes be better intergrated?
  • What relevance-and applicability-does an outcomes-oriented approach hace for developing countries in Asia?

Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence

Moderator: Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit

 

9.50am 

Keynote address

How could an outcomes-oriented approach has enabled Singaporeto develop a healthcare system to meet the needs of its population

Gan Kim Yong, Minister of Health, Singapore

Moderator: Simon Long, Asia Columnist, The Economist

 
10.25am

Networking break

10.50am

Ministerial Dialogue: Assessibility, accountability and affordability

As income rise, as do expectations, much progress has been made in improving health in many Asian countries. Yet the challenges ahead seem ever more daunting. Rapidly ageing societies and the growing burden of non-communicable diseases-among both developed and developing Asian countries-pose fundamental questions of healthcare systems in the region. Here ministers and policymakers reflect on how they are reshaping their respective healthcare systems, and on the appropriateness of an outcomes-oriented approach for their national health strategies.

Liow Tiong Lai, Minister of Health, Malaysia

Nemesio Gako, Assistant Secretary, Department of Health, Republic of the Philippines

Nila Moeloek, Special Envoy of the President of the Republic of Indonesia on Millenium Development Goals

Moderator: Simon Long, Asia Columnist, The Economist

 

11.35am 

Discussion: Information, infrastructure and incentives-Challenges of implementing an outcomes-oriented framework for healthcare systems in Asia

There is no simple transition form provider-and facilities-centric healthcare systems to those that are outcomes-focused, patient-centric and broadly intergraterd across the healthcare and public health spectrums. The focus on quality and outcomes requires new structures, and new information and reward systems to be in place.

  • How are evidence-based standards determined, and outcomes-oriented targets selected? What bodies should be responsible for doing so?
  • What national infrastructure and information systems are necessary so outcomes-focused frameworks can be managed appropriately and effectively?
  • How are the broader determinants of health intergrated into these structures and systems?
  • What role can the private sector play in this process? And how?

David Kalisch, Director (CEO), Australian Institute of Health and Welfare

Paula Wilson, President and Chief Executive Officer, Joint Commission Resources and Joint Commission International

Sarah Muttitt, Chief Information Officer, MOH Holdings, Singapore

Moderator: Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit

 

12.20pm

Case studies: The conundrum of non-communicable diseases

Asia is facing a crisis in non-communicable diseases, and healthcare systems are often ill-prepared to deal with this looming burden, even as many continue to deal with the burden of communicable diseases. Outcomes-oriented approaches, and a simultaneous focus on greater intergration of healthcare and other health-related policy areas, may offer new directions and solutions. This discussion is a prelude to the breakout sessions, which focus on two non-communicable diseases, diabetes and cancer, as examples of how outcomes-oriented policies might be applied in specific diseases areas, and throughout the lifecycle of these diseases.

  • Are chronic diseases largely preventable, or at least better delayed?
  • How important is the role of primary and secondary (screening and diagnosis) prevention? How can outcomes be set and measured around them?
  • Does chronic care have distinct needs as compared to acute care? Should the two be separate, and would this benefit outcomes?
  • What is the importance of patient-centred, outcomes-oriented approaches to chronic diseases, and why the need for a more integrated care enviroment?

Garry Jennings, Director, Baker IDI Heart and Diabetes Institute

Giberto Lopes, Senior Consultant and Medical Oncologist, Johns Hopkins Singapore International Medical Centre

Mary Gospodarowicz, President-Elect, Union for International Cancer Control

Anil Kapur, Managing Director, World Diabetes Foundation

Moderator: Henry Dummett, Director, Asia Pacific, Double Helix Consulting

 

1.05pm

Hypothesis, goals and framework

To facilitate the afternoon breakout discussions, a brief word on assumptions and goals.

Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

Hypothesis

In developed and developing Asia countries, a reduction of diabetes-related deaths by 10% in 20 years (WHO predicts that diabetes deaths are likely to rise by more than 50% in the next 10 years without urgent action.)

In developed and developing Asia countries, a reduction in the mortality rate of cancer by 20 per 100,000 population in 20 years (WHO predicts that deaths from cancer worldwide will continue to rise annually, with an estimated 12m deaths in 2030.) 

 

Goals

Under the hypothesis, we seek to answer the following questions:

  • What policy reorientations would developed- and developing-country healthcare systems in Asia need to make to achieve these outcomes?
  • How practically would such changes be implemented and delivered, and outcomes achieved?
  • What would be the implications for different stakeholders?

 

 

 

Framework

Each stage of the disease lifecycle for both diabetes and cancer (awareness and prevention, detection and diagnosis, treatment and long-term care) has different outcome characteristics and requirements.

 

The following breakout discussions will focus on what needs to be implemented at each stage of the disease lifecycle in order to achieve the hypothetical improvements in outcomes.

 

1.15pm

Lunch 

2.15-4.00pm 

Concurrent breakout sessions: Prevention and diagnosis

Grad Ballroom 1: Diabetes

2.15 pm: Weighing in early is key

Obesity and excess weight are major predictors of diabetes. What public health prevention policies are most effective in helping control weight, thereby reducing the incidence of diabetes, and how best to improve early detection? What are other causes of diabetes—and are these preventable and easily detectable? How are outcomes for prevention and diagnosis of diabetes best set and measured in the public health context?

Minh Chau Nguyen, Country Director, East Meets West Foundation

Wang Shiyong, Senior Health Specialist, The World Bank

Moderator: Henry Dummett, Director, Asia-Pacific, Double Helix Consulting

 

2.55 pm: Concurrent workshops

 

 

 

1: Developing countries in Asia

In developing countries, less than half the people with diabetes are diagnosed. Without timely diagnosis and adequate treatment, complications and morbidity from diabetes rise exponentially.

Topics for discussion:

  • How can prevention and awareness programmes be established in countries where resources are extremely limited?
  • How might public-private partnerships enhance the prevention and diagnosis of diabetes, especially in rural areas?

Discussion leader

Anil Kapur, Managing Director, World Diabetes Foundation

 

 

 

2: Developed countries in Asia

Diabetic demographics are slightly different in the ageing societies of developed countries, posing different challenges for policymakers for prevention and diagnosis.

Topics for discussion:

  • How can schemes that guide and process self-detection be put in place?
  • How can community-based organisations be encouraged to conduct more screening and identification efforts outside the clinical setting?

Discussion leader

Garry Jennings, Director, Baker IDI Heart and Diabetes Institute

3.40 pm: Feedback from the workshops—discussion: The moderator, joined by two discussion leaders, will welcome ideas from the workshops on how to improve diabetes prevention and diagnosis programmes in Asia. 

Grand Ballroom 3: Cancer

2.15 pm: The big “C”—inevitable or largely preventable?

Tobacco use, physical inactivity, poor diets, alcohol use, infection and environmental pollution are known as major risk factors of common cancers. Yet chronic diseases in general, and cancer in particular, continue to place an increasing burden on health systems everywhere. The science tells us that more effective prevention measures, screening and early intervention could prevent much of the cancer burden, or at least delay it. How can primary and secondary prevention measures be improved to raise cancer-related outcomes?

Maqsood Siddiqi, Chairman and Managing Director, Cancer Foundation of India

Rick Evans, Chairman, Columbia Asia

John Boyages, Director, Macquarie University Cancer Institute

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

 

2.55 pm: Concurrent workshops

 

 

 

1: Developing countries in Asia

More than 70% of all cancer deaths occur in low- and middle-income countries. And there is a link with communicable diseases such as hepatitis and tuberculosis, which are the causes of some major cancers, as are rapidly changing lifestyles.  

Topics for discussion:

  • How to improve the effectiveness and efficiency of vaccinations in order to prevent cancer?
  • How to set up infrastructure for cancer diagnosis?

 Discussion leader

Gilberto Lopes, Senior Consultant and Medical Oncologist, Johns Hopkins Singapore International Medical Centr

 

 

2: Developed countries in Asia

Cancer has become the leading cause of death in some developed Asian countries, notably Singapore, Japan and Korea. How can public health policies be improved to prevent cancer in these countries, and better systems of early detection put in place?

Topics for discussion:

  • How important are public policies such as tobacco control or taxation on cigarettes for cancer prevention?
  • How can detection and diagnosis of cancer be made more affordable?

 Discussion leader

Mary Gospodarowicz, President-elect, Union for International Cancer Control

 

3.40 pm: Feedback from the workshops—discussion: The moderator, joined by two discussion leaders, will welcome ideas from the workshops on how to improve cancer prevention programmes in Asia.

 

4.00pm

Networking break

4.30pm 

Interview: How can a universal health system improve health outcomes?

Paula Risikko, Minister of Social Affairs and Health, Finland

Moderator: Simon Long, Asia Columnist, The Economist

 

5.05pm 

Discussion: Outcomes-based health policymaking-Payoffs and pitfalls?

Advocates of an outcomes-oriented approach in healthcare extol its effectiveness in delivering improved performance in healthcare services, and in creating cost and investment efficiencies. “A powerful new accountability framework … designed to focus the whole system from top to bottom on the outcomes achieved for patients” was how one review praised the UK’s new outcomes-oriented focus. But is it so simple? Critics, while often recognising the attractiveness of such an approach, point also to its limitations: the difficulty of separating clinical outcomes from wider determinants of health; the complexity of measuring evidence-based improvements; the sense that outcomes cannot be a sole focus in an integrated, holistic health system.

  • What are the attractions, and limitations, of an outcomes-oriented approach?
  • Should building such an approach into healthcare systems in Asia be a priority?

Shi Guang, Director, Health Policy Research Division, Ministry of Health, China

Lee Chien Earn, Deputy Director of Medical Services, Ministry of Health, Singapore

Martin Sepulveda, Vice-president, IBM Health Industries Research

Peter Sheehan, Professor, Centre for Strategic Economic Studies, Victoria University 

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

 

5.55pm 

Closing remarks 

6.00pm

Cocktail reception

DAY 2

8.00am 

Registration and refreshments

 

8.45am

Executive interview:

 
The Mayo Clinic is a non-profit, patient-centred healthcare system with a considerable track record. This interview explores how the clinic has developed a highly outcomes-oriented approach, examines the strengths and shortcomings of this approach, and asks what learnings there might be for other healthcare systems.

Wyatt Decker, Vice-president, Mayo Clinic

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

  

9.30am

Dialogue: China's healthcare in focus

Five years ago, China set a goal to build “safe, effective, convenient and affordable” health services. Considerable investments have been put into making healthcare more accessible and affordable to the general public, with some modest successes. Yet China’s healthcare system lags the extraordinary progress seen in the broader economy, and improved health outcomes are quite often proving elusive. Healthcare spending remains low as a percentage of GDP, and health costs continue to rise, putting affordable, quality care beyond the reach of many. Some commendable progress has been made but the road ahead is difficult and complex

  • What are China’s health priorities under the 12th Five-year Plan, and does the plan include significant new reform initiatives?
  • What are the major challenges for improving healthcare and health outcomes? Are there new initiatives planned for preventing and controlling non-communicable diseases?
  • How can health be kept affordable, and costs brought under control?
  • Can the disparity of health delivery between urban and rural areas be tackled more effectively?

Shi Guang, Director, Health Policy Research Division, Ministry of Health, China

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

 

10.10am

Networking break 

10.40am-11.50am

Concurrent breakout sessions: Treatment 

 

Grand Ballroom 1: Diabetes

10.40 am: How can a health system provide integrated care to improve outcomes?

Diabetes is complicated because of co-morbidities (the presence and/or effect of one or more disorders or diseases in addition to the primary disease). In order to improve outcomes, the treatment of diabetes needs to be managed holistically, and in an integrated manner. Doing so can be an extraordinary challenge.

Kunho Yoon, Catholic University of Korea

Fikry Isaac, Vice-president, Global Health Services, Johnson & Johnson

Moderator: Henry Dummett, Director, Asia-Pacific, Double Helix Consulting 

 

11:10 am: Concurrent workshops

 

 

 

1: Developing countries in Asia

In the poorest countries, people with diabetes and their immediate families bear almost the full cost of medical treatment and care.

Topics for discussion:

  • How can self-financing schemes be set up to fight diabetes?
  • How can affordable technologies play a bigger role in treatment?    

Discussion leader

Anil Kapur, Managing Director, World Diabetes Foundation

 

 

2: Developed countries in Asia

In developed countries, with technology and resources, how can healthcare systems be more integrated to achieve better outcomes?

Topics for discussion:

  • How can a holistic-care system be set up to achieve better outcomes?
  • How can the larger economic burden imposed by diabetes (lost productivity, foregone economic growth) be offset?

Discussion leader

Garry Jennings, Director, Baker IDI Heart and Diabetes Institute

 

11.40 am: Feedback from the workshops—discussion: The moderator, joined by two discussion leaders, will welcome ideas from the workshops on how to improve outcomes through changes in diabetes treatment.

 

Grand Ballroom 3: Cancer

10.40 am: Cost-effectiveness and cancer treatment 

Cancer care is costly, prolonged and normally multi-disciplinary. Developed countries battle with the rising costs, and outcomes-oriented approaches help decision-makers understand better how to allocate scarce resources and funds. Developing countries face resourcing and financing issues of a different order. How can an outcomes-oriented approach help to manage the financial burden of cancer care, and allocate resources effectively?

Henry Haipeng Zhang, Chief Executive Officer, China Resources Healthcare Group

John Boyages, Director, Macquarie University Cancer Institute

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

 

11.10 am: Concurrent workshops

 

 

 

1: Developing countries in Asia

Expensive cancer treatments and drugs pose a moral dilemma for policymakers in allocating resources in countries that may still struggle with access to basic facilities. 

Topics for discussion:

  • How can scarce resources be best allocated to set up a “basic cancer plan”, such as cancer registries and radiation centres/hospitals?
  • How can the social safety net provide cancer treatment to the very poor?

Discussion leader

Gilberto Lopes, Senior Consultant and Medical Oncologist, Johns Hopkins Singapore International Medical Centre

 

 

 

2: Developed countries in Asia

The medical costs of cancer are soaring in developed Asian countries. How could an outcomes-oriented approach help manage rising costs and distribute funding fairly and efficiently?

Topics for discussion:

  • What institutions and systems are needed to establish standards and measure outcomes and treatment quality?
  • How could reimbursement systems be structured to improve outcomes?

Discussion leader

Mary Gospodarowicz, President-elect, Union for International Cancer Control

 

11.40 am: Feedback from workshops—discussion: The moderator, joined by two discussion leaders, will welcome ideas from the workshops on how to improve outcomes through changes in cancer treatment.

11.50am-12.30pm

Concurrent breakout sessions: Long-term care

Grand Ballroom 1: Diabetes

Quality of life and wellness of diabetics are the ultimate outcome targets.

Panel discussion

  • Is it necessary or possible to build care systems other than hospitals for long-term care?
  • Are self-care systems the answer?
  • What are the policy challenges faced by developing and developed countries?

Nathan Sigworth, Co-founder and Chief Executive Officer, PharmaSecure

Chris Wasden, Global Healthcare Innovation Leader, PricewaterhouseCoopers

Moderator: Henry Dummett, Director, Asia-Pacific, Double Helix Consulting

 

 

Grand Ballroom 3: Cancer

Cancer survivorship is the key outcome against which long-term treatment and care is measured.

Panel discussion

  • How can palliative care and survivorship care be improved?
  • How can survivorship outcomes and their effectiveness be measured?
  • What solutions are appropriate, affordable and applicable in developing contexts?

Elmer Soriano, Country Manager, Philippines, ACCESS Health International

Kenji Shibuya, Professor and Chair, Department of Global Health Policy, University of Tokyo

Moderator: Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

 

12.30pmConclusion: Outcome of the outcomes
 

The conference chairpersons are joined by experts to synthesise the outcomes from the breakout sessions and from the broader conference.

  • What best-practice examples of outcomes-oriented approaches are there, and what are their indicators of success? What learnings do they offer?
  • How can outcomes best be defined and measured? What institutional capabilities are necessary to support effective outcomes-oriented frameworks?
  • What are the policy options and challenges for establishing outcomes-oriented frameworks as drivers of healthcare system performance, and how do these differ between developed and developing country settings in Asia?

Gilberto Lopes, Senior Consultant and Medical Oncologist, Johns Hopkins Singapore International Medical Centre

Peter Sheehan, Professor, Centre for Strategic Economic Studies, Victoria University

Anil Kapur, Managing Director, World Diabetes Foundation

Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit

Henry Dummett, Director, Asia-Pacific, Double Helix Consulting

12.30pm

Conclusion: Outcome of the outcomes (Back to the main room)

The Chairmen and experts from different sectors will synthesise the outcomes of the conference discussions: the ideas, thoughts and proposals that have emerged through the conference..

  • What best-practice examples from around the world, but particularly from within Asia, exist for an outcomes-oriented approach and what are their indicators of success?
  • What lessons could Asian countries learn from these experiences?
  • What do outcomes mean in the context of diabetes and cancer?
  • What criteria do we apply to define the outcomes that are most important to the health of Asian populations?
  • What specific outcomes should different countries within Asia be targeting with regard to diabetes and cancer? 

Gilberto Lopes, Senior Consultant and Medical Oncologist, Johns Hopkins Singapore International Medical Centre

Peter Sheehan, Professor, Victoria University

Anil Kapur, Managing Director, World Diabetes Foundation

Charles Goddard, Editorial Director, Asia-Pacific , Economist Intelligence Unit 

Henry Dummett, Director, Asia Pacific, Double Helix Consulting

 

1.00pmLunch and end of conference

Gan Kim Yong, Minister of Health, Singapore

Mr Gan Kim Yong is the current Health Minister of Singapore. He took office in May 2011 after being re-elected as a Member of Parliament (MP) for the Chua Chu Kang GRC.

Charles Goddard, Editorial Director, Asia Pacific, Economist Intelligence Unit

Charles Goddard leads the Economist Intelligence Unit’s editorial services in Asia-Pacific, including Corporate Network, a peer group for senior decision-makers of global businesses operating in the region.

Simon Long, Asia Columnist, The Economist

Simon Long took up this post, based in Singapore, in August 2010. Before that, he had worked in London for four years, as the magazine’s Asia editor, and for four years prior to that as South Asia bureau chief based in Delhi.

Paula Risikko, Minister of Social Affairs and Health, Finland

Paula Risikko is the Minister of Social Affairs and Health of Finland since June 2011. She is a member of the Finnish Parliament. Until June 2011, she was the Minister of Health and Social Services.

Liow Tiong Lai, Minister of Health, Malaysia

Liow Tiong Lai is currently the minister of health in Malaysia, a post he was appointed to in March 2008, and re-appointed to in April 2009 when Malaysia had a change in premiership.

Shi Guang, Director, Health Policy Research Division, Department of Health Policy and Legislation, Ministry of Health, China

Shi Guang has served as director of the division of health policy research in the Ministry of Health since October 2007.

Nemesio T. Gako, Assistant Secretary of Health, Department of Health, Philippines

Nemesio Gako, assistant secretary of health, leads the administration technical cluster of the Department of Health, Philippines.

Nila Moeloek, Special Envoy on Millenium Development Goals, Office of the President of the Republic of Indonesia

Nila F Moeloek serves as the Special Envoy of the President of the Republic of Indonesia on the Millennium Development Goals (MDGs), a ministerial-level post which she has held since 2010.

Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence

Andrew Dillon is chief executive of the National Institute for Health and Clinical Excellence (NICE). NICE sets healthcare standards for the National Health Service in England and Wales.

Lee Chien Earn, Deputy Director of Medical Services, Ministry of Health, Singapore

Dr Lee is the Deputy Director of Medical Services in the Ministry of Health. He is also an Adjunct Associate Professor at the Department of Epidemiology and Public Health at the Yong Loo Lin School of Medicine in Singapore.

Elmer Soriano, Country Manager, Philippines, ACCESS Health International

Elmer Soriano is the country manager at ACCESS Health International-Philippines and runs a Manila-based health-venture incubator through a partnership with the Ayala Technology Business Incubator.

David Kalisch, Director (CEO), Australian Institute of Health and Welfare

David Kalisch was appointed the chief executive officer of the Australian Institute of Health and Welfare in December 2010. He is an economist with experience across a range of social policy issues.

Professor Garry Jennings AM, Director, Baker IDI Heart and Diabetes Institute

Garry Jennings is the director of the Baker IDI Heart and Diabetes Institute, a cardiovascular and metabolic research centre in Australia.

Maqsood Siddiqi, Chairman and Managing Director, Cancer Foundation of India

Maqsood Siddiqi is a medical scientist with many years of experience in India and abroad. He was director of two major research centres in India, where he guided research in diverse areas such as preventive cancer research and epidemiology.

Rick Evans, Chairman, Columbia Asia

Rick Evans has been a manager in the health care industry for over 30 years. He was the Director of Development for the Hillhaven Corporation for a decade prior to that company’s acquisition by National Medical Enterprises.

Henry Dummett, Director, Asia-Pacific, Double Helix Consulting

Henry Dummett is the Asia-Pacific director of Double Helix Consulting, a strategy consultancy based in Singapore that specialises in developing market access and economic solutions for both pharmaceutical and medical device clients.

Minh Chau Nguyen, Country Director, East Meets West Foundation

Minh Chau Nguyen became the country director for the East Meets West Foundation in March 2009. She was previously a board member and the chief strategy officer.

Martín Sepúlveda, Vice President, Health-Industries Research, IBM Corporation

Martín Sepúlveda is vice-president of health-industries research for the IBM Corporation. He leads a global team of health-industry subject-matter experts, creating transformational assets through research for the healthcare industry.

Gilberto Lopes, Senior Consultant Medical Oncologist and Assistant Director for Clinical Research, Johns Hopkins Singapore International Medical Centre

Gilberto Lopes is a Senior Consultant Medical Oncologist and Assistant Director for Clinical Research at the Johns Hopkins Singapore International Medical Centre and an Assistant Professor of Oncology at the Johns Hopkins University.

Fikry Isaac, Vice President, Global Health Services, Chief Medical Officer, Wellness & Prevention, Johnson & Johnson, Co-chair, APEC Life Sciences Innovation Forum

Fikry Isaac is the vice-president of global health services for Johnson & Johnson. He leads the development of health and wellness strategies, policies, guidelines and services worldwide.

Paula Wilson, President and Chief Executive Officer, Joint Commission Resources and Joint Commission International

Paula Wilson is president and chief executive officer of Joint Commission Resources (JCR) and its international division, Joint Commission International (JCI). Ms Wilson has over 30 years of experience in the health care industry.

John Boyages, Director and Professor of Breast Oncology, Macquarie University Cancer Institute

John Boyages is a cancer specialist with 30 years experience in the diagnosis and treatment of breast cancer. He was the founding director of the Westmead Breast Cancer Institute.

Wyatt Decker, Vice President, Mayo Clinic, Chief Executive Officer for Mayo Clinic in Arizona

Wyatt W. Decker, M.D., is vice president of Mayo Clinic and Chief Executive Officer of Mayo Clinic in Arizona. Dr. Decker is also a professor of emergency medicine at the Mayo Clinic College of Medicine.

Sarah Muttitt, Chief Information Officer, MOH Holdings, Singapore

Dr. Sarah Muttitt brings more than twenty five years experience in the healthcare industry with a clinical background in pediatrics, neonatology and experience in the development and implementation of innovative healthcare technologies.

Nathan Sigworth, Co-Founder and Chief Executive Officer, PharmaSecure

Nathan Sigworth co-founded PharmaSecure in 2007 and became CEO in 2010. With his direction the company has become a market leader in pharmaceutical product authentication in India.

Chris Wasden, Global Healthcare Innovation Leader, PwC

Chris Wasden is a global healthcare innovation leader the healthcare strategy and innovation practice of PricewaterhouseCoopers.

Mary Gospodarowicz, President-Elect, Union for International Cancer Control, Miedical Director, Cancer Programme, Princess Margaret Hospital, Toronto

Mary Gospodarowicz leads the cancer programme at Princess Margaret Hospital and the Cancer Care Ontario regional cancer programme in Toronto.

Kun-Ho Yoon, Vice Chairman and Chief Planning Officer, Catholic Medical Centre, The Catholic University of Korea

Kun Ho Yoon is currently the Vice chairman and chief planning officer at the Catholic Medical Centre.

Kenji Shibuya, Professor and Chair, Department of Global Health Policy, The University of Tokyo

Kenji Shibuya is a professor of global health policy at the University of Tokyo’s Graduate School of Medicine.

Shiyong Wang, Senior Health Specialist, Human Development Unit, East Asia and Pacific Region, The World Bank

Shiyong Wang had worked at different levels of health care system in China for nine years before joined the World Bank in 1999.

Peter Sheehan, Professor, Centre for Strategic Economic Studies, Victoria University

Peter Sheehan is founding director of the Centre for Strategic Economic Studies at Victoria University in Melbourne. He has occupied this position since 1993. He is also co-chair (academic) of the APEC Life Sciences Innovation Forum.

Anil Kapur, Managing Director, World Diabetes Foundation

Anil Kapur, an internist by training, is the managing director of the World Diabetes Foundation. He has been associated with the foundation since its inception in 2002, previously serving as vice chairman of the board.

We are grateful to our Supporting Organisations who have committed their support to Healthcare in Asia 2012.

 

 Held in:
        
 Supported by:
   
Lead sponsor:

  

Supporting sponsors:

 

 

 

 

  

 
Luncheon Sponsor:
 
Official PR partner:
 
Media partners:

 

 

Supporting organisations:

 

 

 

Customer service:
Sally Au
Client Relations Executive
Phone: (852) 2585 3312
Email: conferencesasia@economist.com

Sponsorship opportunities:
Laurence James
Business Director
Phone: (852) 2585 3255
Email: laurencejames@economist.com

Speaking enquiries:
Isabel Cao
Senior Programme and Conference Manager, Asia-Pacific
Email: isabelcao@economist.com
Phone: (852) 2585 3894

Marketing partnerships:
Flora Sam
Event Marketing Executive, Asia-Pacific
Phone: (852) 2585 3841
Email: florasam@economist.com 

Contact us today to pre-register your interest in Healthcare in Asia 2012: 

 

CLICK HERE to register

conferencesasia@economist.com

(852) 2585 3312

 

CategoryFee (in USD)
Standard$2,000
Advance purchase rate (before November 25th)      $1,800
The Economist subscriber rate$1,600
Economist Corporate Network member rate$1,400
Government and practitioner rate$900
NGO and academic rate$500

# All delegates travelling to the event from overseas will enjoy a further 10% discount from the above listed fees - with the exception of the corporate table rate.